pharma · Obese · Hyperlipemia
Suzhou Ribo Life
Suzhou Ribo Life Science Co.
Suzhou Ribo Life is a pharma organization headquartered in CN. Primary therapeutic focus areas include Obese, Hyperlipemia, Non-small Cell Lung Cancer, Rheumatoid Arthritis (RA). NovaPharmaNews links 4 clinical program(s
Company details
- Status
- Public
- HQ
- Beijing, CN
- Founded
- 2007
- Employees
- 32
- Programs
- 4
- Drugs
- 7
- Patents
- 0
UTAA91 injection
Phase 1 · mab · Rheumatoid Arthritis (RA)
UTAA91 injection for Rheumatoid Arthritis (RA) is a Phase 1 program (mab) at Suzhou Ribo Life Science Co. with 1 ClinicalTrials.gov record(s).
Internal code PG-011-9
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Suzhou Ribo Life Science Co.
- Phase
- Phase 1
- Modality
- mab
- Indication
- Rheumatoid Arthritis (RA)
- Status
- active
- Trials
- 1